A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The intent and design of this Phase 3 study is to assess BMN 111 as a therapeutic option for the treatment of children with Achondroplasia.
Epistemonikos ID: 1dcdc1aa6c180c014ae192e5cccf967058db0da5
First added on: May 20, 2024